[Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
Hou
Hai-ling
HL
Department of Radiotherapy, Cancer Hospital, Tianjin Medical University, Tianjin 300060, China. hhl0528@sina.com
Hao
Jian-lei
JL
Pang
Qing-song
QS
Wang
Ping
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D011879:Radiotherapy Dosage
D016190:Carboplatin; D002945:Cisplatin